The Filing Desk

CytoSorbents vs Pulsenmore

CytoSorbents CTSO · Pulsenmore PLSM · Health Care Equipment

CytoSorbents reported revenue of $37 million in fiscal 2025, and Pulsenmore ₪40 million in fiscal 2025, in different currencies. CytoSorbents' revenue grew 4.1% in its latest year, and Pulsenmore's grew 314.3%. Free cash flow was −$13 million at CytoSorbents and −₪33 million at Pulsenmore.

Side by side

CytoSorbentsPulsenmore
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$37M₪40M
Revenue growth4.1%314.3%
Revenue growth a year, last 5 years−2.0%—
Gross margin71.5%84.2%
Operating margin−39.8%—
Net margin−22.1%−39.6%
Free cash flow−$13M−₪33M
Free cash flow margin−33.8%−82.5%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M₪0M
Change in diluted share count14.3%0.6%
Last close$5.13$1.35
P/E at the last close——
Insider trades, last 12 monthsbought $269,332, sold $0—
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
In each company's own currency, fiscal years
CytoSorbentsPulsenmore
Operating margin
Percent of revenue
CytoSorbentsPulsenmore
Free cash flow
In each company's own currency. Cash from operations minus capital expenditure.
CytoSorbentsPulsenmore

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CytoSorbents and Pulsenmore pages.